ReviewNature protocols2025
Mapping T cell dynamics to molecular profiles through behavior-guided transcriptomics.
Review in Nature protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Patient-derived complex organoids are a critical tool to understand and explore pediatric malignant brain tumors.Cancer metastasis reviews · 2026Review
- BEHAV3D Tumor Profiler to map heterogeneous cancer cell behavior in the tumor microenvironment.eLife · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
The rise of cellular immunotherapy for cancer treatment has led to the utilization of immune oncology cocultures to simulate T cell interactions with cancer cells for assessing their antitumor response. Previously, we developed BEHAV3D, a three-dimensional live imaging platform of patient-derived tumor organoid (PDO) and engineered T cell cocultures, that analyzes T cells' dynamics to gain crucial insights into their behavior during tumor targeting. However, live imaging alone cannot determine the molecular drivers behind these behaviors. Conversely, single-cell RNA sequencing (scRNA-seq) allows researchers to analyze the transcriptional profiles of individual cells but lacks spatio-temporal resolution. Here we present an extension to the BEHAV3D protocol, called Behavior-Guided Transcriptomics (BGT), for integration of T cell live imaging data with single-cell transcriptomics, enabling analysis of gene programs linked to dynamic T cell behaviors. BGT uses live imaging data processed by BEHAV3D to guide the experimental setup for cell separation based on their PDO engagement levels subsequently followed by fluorescence-activated cell sorting and scRNA-seq. It then integrates in silico simulations of these experiments to computationally infer T cell behavior on scRNA-seq data, uncovering new biomarkers for both highly functional and ineffective T cells, that could be exploited to enhance therapeutic efficacy. The protocol, designed for users with fundamental cell culture, imaging and programming skills, is readily adaptable to diverse coculture settings and takes one month to perform.
Indexed as
Identifiers
39930061What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.